Bupropion is a drug used to treat depression and help quit smoking. It belongs to a group called antidepressants and works by increasing activity in the brain. This study is testing if bupropion can help reduce tiredness (fatigue) caused by cancer and its treatment. Fatigue is feeling very tired, even if you haven't done much. In this study, some people will take bupropion, and others will take a placebo (a pill that looks like the real drug but has no effect) to see which works better. The study lasts for up to 13 weeks, and involves regular medical check-ups and blood tests. You can join if you are an adult cancer survivor who feels very tired (with a fatigue score of 4 or more on a scale of 0-10) and have finished major cancer treatments.

• Study Length: 13 weeks
• Eligibility: Cancer survivors aged 18+, completed major treatments
• Compensation: Not mentioned, but regular check-ups included

Note: You can't join if you're already taking bupropion or certain other medications, or if you have specific health conditions like seizures or a severe kidney issue.